| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 69 |
| 1 | ERGOCALCIFEROL | 63 |
| 2 | OMALIZUMAB | 55 |
| 3 | METFORMIN | 49 |
| 4 | ACETAMINOPHEN | 45 |
| 5 | OMEPRAZOLE MAGNESIUM | 43 |
| 6 | DUPILUMAB | 36 |
| 7 | METFORMIN ER 500 MG | 36 |
| 8 | METFORMIN ER 750 MG | 36 |
| 9 | DEXAMETHASONE | 35 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAMPHOR (SYNTHETIC), PETROLATUM | 1 | 0.2500 |
| 1 | LOVOTIBEGLOGENE AUTOTEMCEL | 1 | 0.0213 |
| 2 | BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE | 1 | 0.0189 |
| 3 | MOISTURIZER | 1 | 0.0083 |
| 4 | OXICONAZOLE NITRATE | 1 | 0.0058 |
| 5 | MEFENAMIC ACID | 9 | 0.0041 |
| 6 | ACEBUTOLOL HYDROCHLORIDE | 5 | 0.0039 |
| 7 | FLUOCINOLONE ACETONIDE, HYDROQUINONE, AND TRETINOIN | 2 | 0.0036 |
| 8 | GLYCERINE | 1 | 0.0031 |
| 9 | PAMIDRONATE DISODIUM | 8 | 0.0024 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 89 |
| 1 | Corticosteroid [EPC] | 88 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 79 |
| 3 | Provitamin D2 Compound [EPC] | 63 |
| 4 | GLP-1 Receptor Agonist [EPC] | 56 |
| 5 | Anti-IgE [EPC] | 55 |
| 6 | Proton Pump Inhibitor [EPC] | 53 |
| 7 | Benzodiazepine [EPC] | 52 |
| 8 | Kinase Inhibitor [EPC] | 52 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 51 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 63 | 0.0021 |
| 1 | Melanin Synthesis Inhibitor [EPC] | 2 | 0.0018 |
| 2 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 3 | Thyroid Hormone Synthesis Inhibitor [EPC] | 9 | 0.0009 |
| 4 | Glinide [EPC] | 8 | 0.0009 |
| 5 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 6 | Interleukin-17A Antagonist [EPC] | 27 | 0.0007 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |
| 8 | Anti-IgE [EPC] | 55 | 0.0006 |
| 9 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 5 | 0.0006 |